Final hearing threshold determined by PTA (a lower value represents better hearing) · sudden sensorineural hearing loss
Intratympanic corticosteroids showed no clear difference in final hearing threshold determined by PTA (a lower value represents… compared with no treatment or versus placebo (low certainty).
1 finding from 1 review
Adverse eventsb · sudden sensorineural hearing loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Persistent tympanic membrane perforation · sudden sensorineural hearing loss
1 finding from 1 review
Vertigo/dizziness: timing not reported · sudden sensorineural hearing loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vertigo/dizziness: at the time of injection · sudden sensorineural hearing loss
1 finding from 1 review
Ear pain: timing not reported · sudden sensorineural hearing loss
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ear pain: at the time of injection · sudden sensorineural hearing loss
1 finding from 1 review
no estimate extracted
44 participants
Very low
Change in weight (kg) · adults and children with cystic fibrosis
2 findings from 1 review
Change in weight z score · adults and children with cystic fibrosis
2 findings from 1 review
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis
2 findings from 1 review
Increase in appetite (subjective reporting) · adults and children with cystic fibrosis
Appetite stimulants may leads to higher increase in appetite (subjective reporting) compared with placebo (low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · people with drug‐resistant focal epilepsy
1 finding from 1 review
Seizure frequency reduction (3‐month blinded evaluation period) · people with drug‐resistant focal epilepsy
1 finding from 1 review
Treatment withdrawal · people with drug‐resistant focal epilepsy
1 finding from 1 review
Adverse effects · people with drug‐resistant focal epilepsy
1 finding from 1 review
Quality of life · people with drug‐resistant focal epilepsy
1 finding from 1 review
All‐cause mortality · children aged between 6 months and 5 years
Vitamin A supplementation leads to lower all‐cause mortality compared with placebo or usual care (high certainty).
1 finding from 1 review
Vomiting · children aged between 6 months and 5 years
Vitamin A supplementation probably leads to higher vomiting compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Vitamin A deficiency · children aged between 6 months and 5 years
Vitamin A supplementation probably leads to lower vitamin A deficiency compared with placebo or usual care (moderate certainty).
1 finding from 1 review
Mortality due to diarrhoea · children aged between 6 months and 5 years
Vitamin A supplementation leads to lower mortality due to diarrhoea compared with placebo or usual care (high certainty).
1 finding from 1 review